10.86
+0.09%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jackson Acquisition Co II
From its filings with the US Securities and Exchange Commission
Jackson Acquisition Co II is based in Alpharetta, Georgia. Its shares trade on NYSE under the ticker JACS. The SEC classifies its business as blank checks. In the fiscal year to 31 December 2025, it reported net income of $9.1m. At that date it held total assets of $243.2m and shareholders' equity of $220,750.
Placement Units purchased by Roth, at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to us of $8,400,000.
Industry Attractiveness. Macro industry dynamics, including the healthcare regulatory and reimbursement situation, must be favorable on a go-forward basis. Healthcare companies can utilize the extensive networks and insights that members of our management team have built in the sector to drive meaningful operational improvements and efficiency gains or to enhance their strategic position by using technology solutions to differentiate its offering.
Strong Management Team. We will seek to acquire businesses or companies with seasoned and strong management teams. Our team brings a breadth of knowledge and plans to focus on assets that represent the same values, proven track records, and work ethic.
Growth Potential. We will seek to target propositions with significant growth potential with the addition of our management team and resources.
Value Proposition. We will seek businesses or companies with clear value proposition, including how success will be measured and demonstrated to investors and that we believe are positioned to provide attractive risk-adjusted equity returns for our shareholders.
Quoted from its 10-K, filed 20 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 10 Dec 2024
- Employees
- 2
- Head office
- 2655 NORTHWINDS PARKWAY, ALPHARETTA, GA, 30009
- Classification
- Blank Checks
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Richard JacksonChairman of the Board, Chief Executive Officer, since 2024
- Mr. David LawrenceChief Financial Officer
- Mr. J. Nicholas AyersIndependent Director Nominee
- Mr. Paul GabosIndependent Director Nominee
- Mr. Brian MccarthyIndependent Director Nominee
- Mr. Stephan RodgersIndependent Director Nominee
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company has a clear focus on healthcare services and technology sectors.
- Headquartered in Alpharetta, Georgia, with a dedicated IPO date.
- Formed as a blank check company for potential business combinations.
Weaknesses
- No employees beyond two individuals.
- No prior operations or revenue generation.
- Lacks industry and sector classification details.
Opportunities
- Potential to target healthcare industry businesses for acquisition.
- IPO provides capital for future business combinations.
- Blank check structure allows flexibility in selecting targets.
Threats
- Blank check company structure may face regulatory scrutiny.
- No operational history could deter potential partners.
- Limited focus on healthcare may restrict target options.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.